Progenitor/stem cell fate determination: Interactive dynamics of cell cycle and microvesicles

Stem Cells and Development

Volumn 21, Issue 10, 2012, Pages 1627-1638

  Aliotta, Jason M ^a   Lee, David ^a   Puente, Napoleon ^a   Faradyan, Sam ^a   Sears, Edmund H ^a   Amaral, Ashley ^a   Goldberg, Laura ^a   Dooner, Mark S ^a   Pereira, Mandy ^a   Quesenberry, Peter J ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2 INTEGRIN; ALPHA4 INTEGRIN; ALPHA5 INTEGRIN; BETA1 INTEGRIN; BETA2 INTEGRIN; CD31 ANTIGEN; CYTOKINE; INTERLEUKIN 11; INTERLEUKIN 3; INTERLEUKIN 6; L SELECTIN; MESSENGER RNA; PADGEM PROTEIN; STEM CELL FACTOR; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ADHESION; CELL CULTURE; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL FATE; CELL ISOLATION; CELL VACUOLE; CONTROLLED STUDY; EPITHELIUM CELL; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; LUNG ALVEOLUS EPITHELIUM; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION EXPOSURE; STEM CELL;

ANIMALS; BONE MARROW CELLS; CELL ADHESION MOLECULES; CELL CYCLE; CELL DIFFERENTIATION; CELLS, CULTURED; COCULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; CYTOKINES; GENE EXPRESSION PROFILING; LUNG; MALE; MICE; MICE, INBRED C57BL; PULMONARY SURFACTANT-ASSOCIATED PROTEINS; STEM CELLS; TRANSPORT VESICLES;

MUS;

EID: 84862891089     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2011.0550     Document Type: Article

References (45)

1. Habibian HK, SO Peters, CC Hsieh, J Wuu, K Vergilis, CI Grimaldi, J Reilly, JE Carlson, AE Frimberger, et al. (1998).The fluctuating phenotype of the lymphohematopoietic stem cell with cell cycle transit. J Exp Med 188: 393-398.
2. Cerny J, M Dooner, C McAuliffe, H Habibian, K Stencil, V Berrios, J Reilly, J Carlson, AM Cerny, et al. (2002). Homing of purified murine lymphohematopoietic stem cells: a cytokine-induced defect. J Hematother Stem Cell Res 11:913-922.
3. Colvin GA, MS Dooner, GJ Dooner, FM Sanchez-Guijo, DA Demers, M Abedi, M Ramanathan, S Chung, S Pascual and PJ Quesenberry. (2007). Stem cell continuum: directed differentiation hotspots. Exp Hematol 35:96-107.
4. Colvin GA, JF Lambert, JE Carlson, CI McAuliffe, M Abedi and PJ Quesenberry. (2002). Rhythmicity of engraftment and altered cell cycle kinetics of cytokine-cultured murine marrow in simulated microgravity compared with static cultures. In Vitro Cell Dev Biol Anim 38:343-351.
5. Colvin GA, JF Lambert, BE Moore, JE Carlson, MS Dooner, M Abedi, J Cerny and PJ Quesenberry. (2004). Intrinsic hematopoietic stem cell/progenitor plasticity: inversions. J Cell Physiol 199:20-31.
6. Dooner GJ, GA Colvin, MS Dooner, KW Johnson and PJ Quesenberry. (2008). Gene expression fluctuations in murine hematopoietic stem cells with cell cycle progression. J Cell Physiol 214:786-795.
7. Becker PS, SK Nilsson, Z Li, VM Berrios, MS Dooner, CL Cooper, CC Hsieh and PJ Quesenberry. (2007). Adhesion receptor expression by hematopoietic cell lines and murine pro genitors: modulation by cytokines and cell cycle status. Exp Hematol 27:533-541.
8. Berrios VM, GJ Dooner, G Nowakowski, A Frimberger, H Valinski, PJ Quesenberry and PS Becker. (2001). The molecular basis for the cytokine-induced defect in homing and engraftment of hematopoietic stem cells. Exp Hematol 29:1326-1335.
9. Reddy GP, CI McAuliffe, L Pang, PJ Quesenberry and I Bertoncello. (2002). Cytokine receptor repertoire and cytokine responsiveness of Ho dull/Rh dull stem cells with differing potentials for G1/S phase progression. Exp Hematol 30:792-800.
10. Quesenberry PJ, GJ Dooner, M DelTatto, GA Colvin, K Johnson and MS Dooner. (2010). Expression of cell cycle related genes with cytokine-induced cell cycle progression of primitive hematopoietic stem cells. Stem Cells Dev 19:453-460.
11. Colvin GA, D Berz, L Liu, MS Dooner, G Dooner, S Pascual, S Chung, Y Sui and PJ Quesenberry. (2010). Heterogeneity of non-cycling and cycling synchronized murine hematopoietic stem/progenitor cells. Cell Physiol 222:57-65.
12. Dooner MS, JM Aliotta, J Pimentel, GJ Dooner, M Abedi, G Colvin, Q Liu, HU Weier, KW Johnson and PJ Quesenberry. (2008). Conversion potential of marrow cells into lung cells fluctuates with cytokine-induced cell cycle. Stem Cells Dev 17:207-219.
13. Quesenberry PJ, GA Colvin and JF Lambert. (2002). The chiaroscuro stem cell: a unified stem cell theory. Blood 100: 4266-4271.
14. Lambert JF, M Liu, GA Colvin, M Dooner, CI McAuliffe, PS Becker, BG Forget, SM Weissman and PJ Quesenberry. (2003). Marrow stem cells shift gene expression and engraftment phenotype with cell cycle transit. J Exp Med 197:1563-1572.
15. Quesenberry P, G Colvin, JF Lambert, M Abedi, J Cerny, M Dooner, B Moore, C McAuliffe, D Demers, et al. (2003). Marrow stem cell potential within a continuum. Ann N Y Acad Sci 996:209-221.
16. Quesenberry PJ, GA Colvin, M Abedi, JF Lambert, B Moore, D Demers, D Greer, C McAuliffe, M Dooner, et al. (2003). The marrow stem cell: the continuum. Bone Marrow Transplant 32 (Suppl. 1):S19-S22.
17. Quesenberry PJ, G Dooner, G Colvin and M Abedi. (2005). Stem cell biology and the plasticity polemic. Exp Hematol 33:389-394.
18. Quesenberry P, M Abedi, M Dooner, G Colvin, FM Sanchez-Guijo, J Aliotta, J Pimentel, G Dooner, D Greer, et al. (2005). The marrow cell continuum: stochastic determinism. Folia Histochem Cytobiol 43:187-190.
19. Quesenberry PJ. (2006). The continuum model of marrow stem cell regulation. Curr Opin Hematol 13:216-221.
20. Quesenberry PJ, G Dooner, M Dooner and G Colvin. (2005). The stem cell continuum: considerations on the heterogeneity and plasticity of marrow stem cells. Stem Cell Rev 1:29-36.
21. Quesenberry PJ, G Colvin, G Dooner, M Dooner, JM Aliotta and K Johnson. (2007). The stem cell continuum: cell cycle, injury, and phenotype lability. Ann N Y Acad Sci 106:20-29.
22. Quesenberry PJ and JM Aliotta. (2008). The paradoxical dynamism of marrow stem cells: considerations of stem cells, niches, and microvesicles. Stem Cell Rev 4:137-147.
23. Quesenberry PJ, GJ Dooner and MS Dooner. (2009). Problems in the promised land: status of adult marrow stem cell biology. Exp Hematol 37:775-783.
24. Aliotta JM, FM Sanchez-Guijo, GJ Dooner, KW Johnson, MS Dooner, KA Greer, D Greer, J Pimentel, LM Kolankiewicz, et al. (2007). Alteration of marrow gene expression, protein production and engraftment into lung by lung-derived microvesicles. Stem Cells 9:2245-2256.
25. Aliotta JM, M Pereira, KW Johnson, N de Paz, MS Dooner, N Puente, C Ayala, K Brilliant, D Berz, et al. (2010). Microvesicle entry into marrow cells mediates tissue-specific changes in mRNA by direct delivery of mRNA and induction of transcription. Exp Hematol 38:233-245.
26. P Wolf. (1967). The nature and significance of platelet products in human plasma. Br J Haematol 13:269-288.
27. Théry C, M Ostrowski and E Segura. (2009). Membrane vesicles as conveyors of immune responses. Nature Rev Immunol 9:581-593.
28. Keller S, MP Sanderson and A Stoeck. (2006). Exosomes: from biogenesis and secretion to biological function. Immunol Lett 107:102-108.
29. Morel O, F Toti, B Hugel and JM Freyssinet. (2004). Cellular microparticles: a disseminated storage pool of bioactive vascular effectors. Curr Opin Hematol 11:156-164.
30. Heijnen HF, AE Schiel, R Fijnheer, HJ Geuze, and JJ Sixma. (1999). Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alphagranules. Blood 94:3791-3799.
31. Janowska-Wieczorek A, M Majka, J Kijowski, M Baj-Krzyworzeka, R Reca, AR Turner, J Ratajczak, SG Emareson, MA Kowalska and MZ Ratajczak. (2001). Platelet-derived microparticles bind to hematopoietic stem/progenitor cells and enhance their engraftment. Blood 98:3143-3149.
32. Gilbert GE, PJ Sims, T Wiedmer, B Furie, BC Furie and SJ Shattil. (1991). Platelet-derived microparticles express high affinity receptors for factor VIII. J Biol Chem 266:17261-17268.
33. Little SR, DM Lynn, Q Ge, DG Anderson, SV Puram, J Chen, HN Eisen and R Langer. (2004). Poly-beta amino estercontaining microparticles enhance the activity of nonviral genetic vaccines. Proc Natl Acad Sci U S A 101:9534-9539.
34. Ratajczak MZ. (2006). Microvesicles: from ''dust to crown.'' Blood 108:2885.
35. Baj-Krzyworzeka M, R Szatanek, K Weglarczyk, J Baran, B Urbanowicz, P Branski, MZ Ratajczak and M Zembala. (2006). Tumour-derived microvesicles carry several surface determinants and mRNA of tumour cells and transfer some of these determinants to monocytes. Cancer Immunol Imunother 55:808-818.
36. Rozmyslowicz T, M Majka, J Kijowski, SL Murphy, DO Conover, M Poncz, J Ratajczak, GN Gaulton and MZ Ratajczak. (2003). Platelet and megakaryocyte-derived microparticles transfer CXCR4 receptor to CXCR4-null cells and make them susceptible to infection by.4-HIV. AIDS 17:33-42.
37. Graves LE, EV Ariztia, JR Navari, HJ Matzel, MS Stack, and DA Fishman. (2004). Proinvasive properties of ovarian cancer ascites-derived membrane vesicles. Cancer Res 64:7045-7049.
38. Fackler OT and BM Peterlin. (2000). Endocytic entry of HIV-1. Curr Biol 10:1005-1008.
39. Fevrier B, D Vilette and F Archer. (2004). Cells release prions in association with exosomes. Proc Natl Acad Sci U S A 100:10592-10597.
40. Ratajczak J, K Miekus, M Kucia, J Zhang, R Reca, P Dvorak and MZ Ratajczak. (2006). Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia 20:847-856.
41. Holmgren L, A Szeles, R Rajnavolgyi, J Folkman, G Klein, I Ernberg and KI Falk. (1999). Horizontal transfer of DNA by the uptake of apoptotic bodies. Blood 93:3956-3963.
42. Hakelien AM, HB Landsverk, JM Rob, BS Skalhegg and P Collas. (2002). Reprogramming fibroblasts to express T-cell functions using cell extracts. Nat Biotech 20:460-466.
43. Deregibus MC, V Cantaluppi, R Calogero, M Lo Iacono, C Tetta, L Biancone, S Bruno, B Bussolati, and G Camussi. (2007). Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. Blood 110:2440-2448.
44. Renzulli JF 2nd, M DelTatto, G Dooner, J Aliotta, L Goldstein, M Dooner, G Colvin, D Chatterjee, PJ Quesenberry. (2010). Microvesicle induction of prostate specific gene expression in normal human bone marrow cells. J Urol 184:2165-2171.
45. Livak KJ and TD Schmittgen. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25:402-408.